Problem statement: Answer the MCQ question.
Query: Which drug has a -0.902\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CC(C)CCN1NC2(CCCC(C)C2)NC1=S
[b] C=CCn1c(SCC(=O)NCC2CCCO2)nc2scc(-c3ccccc3)c2c1=O
[c] O=C1CC(c2ccccc2F)c2c(c3ccccc3[nH]c2=O)O1
Answer: b. C=CCn1c(SCC(=O)NCC2CCCO2)nc2scc(-c3ccccc3)c2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCn1c(SCC(=O)NCC2CCCO2)nc2scc(-c3ccccc3)c2c1=O
C=CCn1c(SCC(=O)NCC2CCCO2)nc2scc(-c3ccccc3)c2c1=O
N-(oxolan-2-ylmethyl)-2-(4-oxo-5-phenyl-3-prop-2-enylthieno[2,3-d]pyrimidin-2-yl)sulfanylacetamide